Home  /  Resource Library  /  Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale

Study investigated the efficacy of subcutaneous rituximab for treatment of diffuse large b-cell and follicular lymphomas.